AI Science Tracker
EN

Deep learning predicts onset acceleration of 38 age-associated diseases from blood and body composition biomarkers in the UK Biobank.

Affiliation not stated in the reviewed material · 27 Jun 2025 · medicine

Discovery

Deep learning predicts onset acceleration of 38 age-associated diseases from blood and body composition biomarkers in the UK Biobank.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary source Methods/Results confirm the represented result: Neural-network Cox model predicts onset acceleration for 38 age-associated diseases in 60,396 UK Biobank participants with C-index evaluation, a distinct epidemiological result.

Technology: Neural-network Cox model predicts onset acceleration for 38 age-associated diseases in 60,396 UK Biobank participants with C-index evaluation, a distinct epidemiological result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Neural-network Cox model predicts onset acceleration for 38 age-associated diseases in 60,396 UK Biobank participants with C-index evaluation, a distinct epidemiological result.
Test and result
Neural-network Cox model predicts onset acceleration for 38 age-associated diseases in 60,396 UK Biobank participants with C-index evaluation, a distinct epidemiological result.
Limitation / still unknown
The source reports the defined cohort/experiment and its reference or test comparison; interpretation is restricted to that study design.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1007/s11357-025-01702-w

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.